store at low temperature
store at -80°C
Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 222.00 | |
5 mg | In stock | $ 463.00 | |
10 mg | In stock | $ 878.00 | |
25 mg | In stock | $ 1,280.00 | |
50 mg | In stock | $ 1,760.00 |
Description | Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells. |
In vitro | Mupadolimab induces increased expression of markers associated with B cell maturation and antigen presentation, transformation into plasma cells, as well as increased secretion of IgM and IgG[1]. |
In vivo | Mupadolimab (10 mg/kg; intraperitoneal injection; once daily for 15 days) stimulates antigen-specific humoral immunity in NSG-SGM3 mice infected with SARS-CoV-2[1]. |
Synonyms | CPI-006 |
Molecular Weight | N/A |
CAS No. | 2451856-97-4 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mupadolimab 2451856-97-4 Immunology/Inflammation CD73 CPI006 CPI-006 CPI 006 inhibitor inhibit